• Company
    • Our Vision
    • Leadership
    • Board of Directors
    • Advisors
    • Partners
      • Partner with Us
  • R&D
    • Pipeline
      • Sofpironium Bromide
      • BBI-3000
      • BBI-6000
    • Clinical Trials
  • Therapeutic Areas
    • Hyperhidrosis
    • Cutaneous T-cell Lymphoma
    • Psoriasis
    • Helpful Resources
  • Investors
    • Investor Overview
    • News
    • Events & Presentations
      • IR Calendar
    • Governance
      • Leadership
      • Board of Directors
      • Committee Composition
      • Governance Documents
    • SEC Filings
  • Contact Us
Brickell Biotech, Inc
  • Company
    • Our Vision
    • Leadership
    • Board of Directors
    • Advisors
    • Partners
      • Partner with Us
  • R&D
    • Pipeline
      • Sofpironium Bromide
      • BBI-3000
      • BBI-6000
    • Clinical Trials
  • Therapeutic Areas
    • Hyperhidrosis
    • Cutaneous T-cell Lymphoma
    • Psoriasis
    • Helpful Resources
  • Investors
    • Investor Overview
    • News
    • Events & Presentations
      • IR Calendar
    • Governance
      • Leadership
      • Board of Directors
      • Committee Composition
      • Governance Documents
    • SEC Filings
  • Contact Us

Events & Presentations

mail icon

Sign Up For Email Alerts

Sign up today

OUR COMPANY

  • Our Vision
  • Leadership
  • Board of Directors
  • Advisors
  • Partners

R&D

  • Pipeline
  • Clinical Trials

THERAPEUTIC AREAS

  • Hyperhidrosis
  • Cutaneous T-cell Lymphoma
  • Psoriasis
  • Helpful Resources

INVESTORS

  • Investors Overview
  • News
  • Events & Presentations
  • Governance
  • SEC Fillings

©2019 Brickell Biotech, Inc.

Contact Us | Privacy Policy | Terms of Use

Designed by Clinically Media